Systemic gabapentin and S(+)-3-isobutyl-γ-aminobutyric acid block secondary hyperalgesia

Gabapentin (GBP) and S(+)-3-isobutyl-γ-aminobutyric acid (IBG) are anticonvulsant agents which are effective against many clinical and experimental neuropathic pain states. We examined the efficacy of these agents in a new rat model of secondary mechanical hyperalgesia generated by a mild thermal in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain research 1998-11, Vol.810 (1), p.93-99
Hauptverfasser: Jones, Denise L., Sorkin, Linda S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 99
container_issue 1
container_start_page 93
container_title Brain research
container_volume 810
creator Jones, Denise L.
Sorkin, Linda S.
description Gabapentin (GBP) and S(+)-3-isobutyl-γ-aminobutyric acid (IBG) are anticonvulsant agents which are effective against many clinical and experimental neuropathic pain states. We examined the efficacy of these agents in a new rat model of secondary mechanical hyperalgesia generated by a mild thermal injury. Under brief halothane anesthesia, an injury was induced by applying one heel to a hot surface (52.5°C) for 45 s. GBP, IBG or saline was injected i.p. just prior to the injury. Mean mechanical withdrawal threshold (MWT) was determined using von Frey hairs before and at 30 min intervals for 3 h following the injury. MWT outside the injury area decreased post-injury (secondary hyperalgesia, allodynia), but primary (site of injury) mechanical hyperalgesia was not observed. Secondary hyperalgesia exhibited a tendency toward recovery over time. Time to onset of the anti-allodynic effect of GBP was 30–60 min. The minimum effective GBP dose was 100 mg/kg; 300 mg/kg GBP totally inhibited the drop in MWT, but was accompanied by pronounced sedation. Anti-allodynic effects of IBG were apparent at the first post-injury measure of MWT (30 min). Thirty milligrams per kilogram was the minimum effective dose; 100 mg/kg IBG totally blocked the allodynia with minimal side effects. Our findings demonstrate a dose-dependent blockade of the mechanical sensitivity caused by a mild thermal injury by both GBP and IBG. Results indicate that IBG is more effective than GBP in this model at doses which do not cause sedation. These observations support the suggested use of these or related γ-amino acid analogues as an effective treatment for post-operative pain.
doi_str_mv 10.1016/S0006-8993(98)00890-7
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70054003</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006899398008907</els_id><sourcerecordid>17100214</sourcerecordid><originalsourceid>FETCH-LOGICAL-c445t-8daab79502306e0e7ae68773fc89c95433444a19bac043f67b31f488ea0b98493</originalsourceid><addsrcrecordid>eNqFkM1O3DAQgK2Kii7QR0DKASFQ5TKOndg-VRUCWgmphy0HTtbEmVC3-VnsLNI-F-_BMzX7IzhyGo3mm7-PsWMBXwWI8mIOACU31soza84BjAWuP7CZMDrnZa5gj81ekU_sIKW_UyqlhX22b42QeWFn7H6-SiN1wWcPWOGC-jH0GfZ1Nj_7cs4lD2moluOq5S_PHLvQb7I44ehDnVXt4P9lifzQ1xhX2Z_VgiK2D5QCHrGPDbaJPu_iIbu7vvp9-YPf_rr5efn9lnulipGbGrHStoBcQklAGqk0WsvGG-ttoaRUSqGwFXpQsil1JUWjjCGEyhpl5SE73c5dxOFxSWl0XUie2hZ7GpbJaYBCrR9_DxRaAORCTWCxBX0cUorUuEUM3fSfE-DW7t3GvVuLdda4jXunp77j3YJl1VH92rWTPdVPdnVMHtsmYu9DehtemNKYcsK-bTGarD0Fii75QL2nOkTyo6uH8M4h_wE4PaAy</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17100214</pqid></control><display><type>article</type><title>Systemic gabapentin and S(+)-3-isobutyl-γ-aminobutyric acid block secondary hyperalgesia</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Jones, Denise L. ; Sorkin, Linda S.</creator><creatorcontrib>Jones, Denise L. ; Sorkin, Linda S.</creatorcontrib><description>Gabapentin (GBP) and S(+)-3-isobutyl-γ-aminobutyric acid (IBG) are anticonvulsant agents which are effective against many clinical and experimental neuropathic pain states. We examined the efficacy of these agents in a new rat model of secondary mechanical hyperalgesia generated by a mild thermal injury. Under brief halothane anesthesia, an injury was induced by applying one heel to a hot surface (52.5°C) for 45 s. GBP, IBG or saline was injected i.p. just prior to the injury. Mean mechanical withdrawal threshold (MWT) was determined using von Frey hairs before and at 30 min intervals for 3 h following the injury. MWT outside the injury area decreased post-injury (secondary hyperalgesia, allodynia), but primary (site of injury) mechanical hyperalgesia was not observed. Secondary hyperalgesia exhibited a tendency toward recovery over time. Time to onset of the anti-allodynic effect of GBP was 30–60 min. The minimum effective GBP dose was 100 mg/kg; 300 mg/kg GBP totally inhibited the drop in MWT, but was accompanied by pronounced sedation. Anti-allodynic effects of IBG were apparent at the first post-injury measure of MWT (30 min). Thirty milligrams per kilogram was the minimum effective dose; 100 mg/kg IBG totally blocked the allodynia with minimal side effects. Our findings demonstrate a dose-dependent blockade of the mechanical sensitivity caused by a mild thermal injury by both GBP and IBG. Results indicate that IBG is more effective than GBP in this model at doses which do not cause sedation. These observations support the suggested use of these or related γ-amino acid analogues as an effective treatment for post-operative pain.</description><identifier>ISSN: 0006-8993</identifier><identifier>EISSN: 1872-6240</identifier><identifier>DOI: 10.1016/S0006-8993(98)00890-7</identifier><identifier>PMID: 9813259</identifier><identifier>CODEN: BRREAP</identifier><language>eng</language><publisher>London: Elsevier B.V</publisher><subject>Acetates - administration &amp; dosage ; Acetates - pharmacology ; Allodynia ; Amines ; Animals ; Anticonvulsants - administration &amp; dosage ; Anticonvulsants - pharmacology ; Anticonvulsants. Antiepileptics. Antiparkinson agents ; Biological and medical sciences ; Burns - complications ; Cyclohexanecarboxylic Acids ; Dose-Response Relationship, Drug ; Gabapentin ; gamma-Aminobutyric Acid - administration &amp; dosage ; gamma-Aminobutyric Acid - analogs &amp; derivatives ; gamma-Aminobutyric Acid - pharmacology ; Hyperalgesia - etiology ; Hyperalgesia - prevention &amp; control ; Injections, Intraperitoneal ; Male ; Medical sciences ; Neuropharmacology ; Pain ; Pain modulation ; Pain Threshold - drug effects ; Pharmacology ; Pharmacology. Drug treatments ; Pregabalin ; Rat ; Rats ; Rats, Sprague-Dawley ; Thermal injury</subject><ispartof>Brain research, 1998-11, Vol.810 (1), p.93-99</ispartof><rights>1998 Elsevier Science B.V.</rights><rights>1999 INIST-CNRS</rights><rights>Copyright 1998 Elsevier Science B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c445t-8daab79502306e0e7ae68773fc89c95433444a19bac043f67b31f488ea0b98493</citedby><cites>FETCH-LOGICAL-c445t-8daab79502306e0e7ae68773fc89c95433444a19bac043f67b31f488ea0b98493</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0006-8993(98)00890-7$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1586886$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9813259$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jones, Denise L.</creatorcontrib><creatorcontrib>Sorkin, Linda S.</creatorcontrib><title>Systemic gabapentin and S(+)-3-isobutyl-γ-aminobutyric acid block secondary hyperalgesia</title><title>Brain research</title><addtitle>Brain Res</addtitle><description>Gabapentin (GBP) and S(+)-3-isobutyl-γ-aminobutyric acid (IBG) are anticonvulsant agents which are effective against many clinical and experimental neuropathic pain states. We examined the efficacy of these agents in a new rat model of secondary mechanical hyperalgesia generated by a mild thermal injury. Under brief halothane anesthesia, an injury was induced by applying one heel to a hot surface (52.5°C) for 45 s. GBP, IBG or saline was injected i.p. just prior to the injury. Mean mechanical withdrawal threshold (MWT) was determined using von Frey hairs before and at 30 min intervals for 3 h following the injury. MWT outside the injury area decreased post-injury (secondary hyperalgesia, allodynia), but primary (site of injury) mechanical hyperalgesia was not observed. Secondary hyperalgesia exhibited a tendency toward recovery over time. Time to onset of the anti-allodynic effect of GBP was 30–60 min. The minimum effective GBP dose was 100 mg/kg; 300 mg/kg GBP totally inhibited the drop in MWT, but was accompanied by pronounced sedation. Anti-allodynic effects of IBG were apparent at the first post-injury measure of MWT (30 min). Thirty milligrams per kilogram was the minimum effective dose; 100 mg/kg IBG totally blocked the allodynia with minimal side effects. Our findings demonstrate a dose-dependent blockade of the mechanical sensitivity caused by a mild thermal injury by both GBP and IBG. Results indicate that IBG is more effective than GBP in this model at doses which do not cause sedation. These observations support the suggested use of these or related γ-amino acid analogues as an effective treatment for post-operative pain.</description><subject>Acetates - administration &amp; dosage</subject><subject>Acetates - pharmacology</subject><subject>Allodynia</subject><subject>Amines</subject><subject>Animals</subject><subject>Anticonvulsants - administration &amp; dosage</subject><subject>Anticonvulsants - pharmacology</subject><subject>Anticonvulsants. Antiepileptics. Antiparkinson agents</subject><subject>Biological and medical sciences</subject><subject>Burns - complications</subject><subject>Cyclohexanecarboxylic Acids</subject><subject>Dose-Response Relationship, Drug</subject><subject>Gabapentin</subject><subject>gamma-Aminobutyric Acid - administration &amp; dosage</subject><subject>gamma-Aminobutyric Acid - analogs &amp; derivatives</subject><subject>gamma-Aminobutyric Acid - pharmacology</subject><subject>Hyperalgesia - etiology</subject><subject>Hyperalgesia - prevention &amp; control</subject><subject>Injections, Intraperitoneal</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Pain</subject><subject>Pain modulation</subject><subject>Pain Threshold - drug effects</subject><subject>Pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Pregabalin</subject><subject>Rat</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Thermal injury</subject><issn>0006-8993</issn><issn>1872-6240</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM1O3DAQgK2Kii7QR0DKASFQ5TKOndg-VRUCWgmphy0HTtbEmVC3-VnsLNI-F-_BMzX7IzhyGo3mm7-PsWMBXwWI8mIOACU31soza84BjAWuP7CZMDrnZa5gj81ekU_sIKW_UyqlhX22b42QeWFn7H6-SiN1wWcPWOGC-jH0GfZ1Nj_7cs4lD2moluOq5S_PHLvQb7I44ehDnVXt4P9lifzQ1xhX2Z_VgiK2D5QCHrGPDbaJPu_iIbu7vvp9-YPf_rr5efn9lnulipGbGrHStoBcQklAGqk0WsvGG-ttoaRUSqGwFXpQsil1JUWjjCGEyhpl5SE73c5dxOFxSWl0XUie2hZ7GpbJaYBCrR9_DxRaAORCTWCxBX0cUorUuEUM3fSfE-DW7t3GvVuLdda4jXunp77j3YJl1VH92rWTPdVPdnVMHtsmYu9DehtemNKYcsK-bTGarD0Fii75QL2nOkTyo6uH8M4h_wE4PaAy</recordid><startdate>19981109</startdate><enddate>19981109</enddate><creator>Jones, Denise L.</creator><creator>Sorkin, Linda S.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>19981109</creationdate><title>Systemic gabapentin and S(+)-3-isobutyl-γ-aminobutyric acid block secondary hyperalgesia</title><author>Jones, Denise L. ; Sorkin, Linda S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c445t-8daab79502306e0e7ae68773fc89c95433444a19bac043f67b31f488ea0b98493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Acetates - administration &amp; dosage</topic><topic>Acetates - pharmacology</topic><topic>Allodynia</topic><topic>Amines</topic><topic>Animals</topic><topic>Anticonvulsants - administration &amp; dosage</topic><topic>Anticonvulsants - pharmacology</topic><topic>Anticonvulsants. Antiepileptics. Antiparkinson agents</topic><topic>Biological and medical sciences</topic><topic>Burns - complications</topic><topic>Cyclohexanecarboxylic Acids</topic><topic>Dose-Response Relationship, Drug</topic><topic>Gabapentin</topic><topic>gamma-Aminobutyric Acid - administration &amp; dosage</topic><topic>gamma-Aminobutyric Acid - analogs &amp; derivatives</topic><topic>gamma-Aminobutyric Acid - pharmacology</topic><topic>Hyperalgesia - etiology</topic><topic>Hyperalgesia - prevention &amp; control</topic><topic>Injections, Intraperitoneal</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Pain</topic><topic>Pain modulation</topic><topic>Pain Threshold - drug effects</topic><topic>Pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Pregabalin</topic><topic>Rat</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Thermal injury</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jones, Denise L.</creatorcontrib><creatorcontrib>Sorkin, Linda S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jones, Denise L.</au><au>Sorkin, Linda S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Systemic gabapentin and S(+)-3-isobutyl-γ-aminobutyric acid block secondary hyperalgesia</atitle><jtitle>Brain research</jtitle><addtitle>Brain Res</addtitle><date>1998-11-09</date><risdate>1998</risdate><volume>810</volume><issue>1</issue><spage>93</spage><epage>99</epage><pages>93-99</pages><issn>0006-8993</issn><eissn>1872-6240</eissn><coden>BRREAP</coden><abstract>Gabapentin (GBP) and S(+)-3-isobutyl-γ-aminobutyric acid (IBG) are anticonvulsant agents which are effective against many clinical and experimental neuropathic pain states. We examined the efficacy of these agents in a new rat model of secondary mechanical hyperalgesia generated by a mild thermal injury. Under brief halothane anesthesia, an injury was induced by applying one heel to a hot surface (52.5°C) for 45 s. GBP, IBG or saline was injected i.p. just prior to the injury. Mean mechanical withdrawal threshold (MWT) was determined using von Frey hairs before and at 30 min intervals for 3 h following the injury. MWT outside the injury area decreased post-injury (secondary hyperalgesia, allodynia), but primary (site of injury) mechanical hyperalgesia was not observed. Secondary hyperalgesia exhibited a tendency toward recovery over time. Time to onset of the anti-allodynic effect of GBP was 30–60 min. The minimum effective GBP dose was 100 mg/kg; 300 mg/kg GBP totally inhibited the drop in MWT, but was accompanied by pronounced sedation. Anti-allodynic effects of IBG were apparent at the first post-injury measure of MWT (30 min). Thirty milligrams per kilogram was the minimum effective dose; 100 mg/kg IBG totally blocked the allodynia with minimal side effects. Our findings demonstrate a dose-dependent blockade of the mechanical sensitivity caused by a mild thermal injury by both GBP and IBG. Results indicate that IBG is more effective than GBP in this model at doses which do not cause sedation. These observations support the suggested use of these or related γ-amino acid analogues as an effective treatment for post-operative pain.</abstract><cop>London</cop><cop>Amsterdam</cop><cop>New York, NY</cop><pub>Elsevier B.V</pub><pmid>9813259</pmid><doi>10.1016/S0006-8993(98)00890-7</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-8993
ispartof Brain research, 1998-11, Vol.810 (1), p.93-99
issn 0006-8993
1872-6240
language eng
recordid cdi_proquest_miscellaneous_70054003
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Acetates - administration & dosage
Acetates - pharmacology
Allodynia
Amines
Animals
Anticonvulsants - administration & dosage
Anticonvulsants - pharmacology
Anticonvulsants. Antiepileptics. Antiparkinson agents
Biological and medical sciences
Burns - complications
Cyclohexanecarboxylic Acids
Dose-Response Relationship, Drug
Gabapentin
gamma-Aminobutyric Acid - administration & dosage
gamma-Aminobutyric Acid - analogs & derivatives
gamma-Aminobutyric Acid - pharmacology
Hyperalgesia - etiology
Hyperalgesia - prevention & control
Injections, Intraperitoneal
Male
Medical sciences
Neuropharmacology
Pain
Pain modulation
Pain Threshold - drug effects
Pharmacology
Pharmacology. Drug treatments
Pregabalin
Rat
Rats
Rats, Sprague-Dawley
Thermal injury
title Systemic gabapentin and S(+)-3-isobutyl-γ-aminobutyric acid block secondary hyperalgesia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T10%3A47%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Systemic%20gabapentin%20and%20S(+)-3-isobutyl-%CE%B3-aminobutyric%20acid%20block%20secondary%20hyperalgesia&rft.jtitle=Brain%20research&rft.au=Jones,%20Denise%20L.&rft.date=1998-11-09&rft.volume=810&rft.issue=1&rft.spage=93&rft.epage=99&rft.pages=93-99&rft.issn=0006-8993&rft.eissn=1872-6240&rft.coden=BRREAP&rft_id=info:doi/10.1016/S0006-8993(98)00890-7&rft_dat=%3Cproquest_cross%3E17100214%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17100214&rft_id=info:pmid/9813259&rft_els_id=S0006899398008907&rfr_iscdi=true